Lazard Asset Management LLC bought a new position in shares of Aspen Aerogels, Inc. (NYSE:ASPN – Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 141,745 shares of the construction company’s stock, valued at approximately $485,000. Lazard Asset Management LLC owned 0.17% of Aspen Aerogels at the end of the most recent quarter.
Other institutional investors and hedge funds have also bought and sold shares of the company. Acadian Asset Management LLC bought a new position in Aspen Aerogels in the 1st quarter valued at $43,000. Tower Research Capital LLC TRC increased its holdings in shares of Aspen Aerogels by 184.6% in the second quarter. Tower Research Capital LLC TRC now owns 7,235 shares of the construction company’s stock worth $43,000 after purchasing an additional 4,693 shares during the period. Prelude Capital Management LLC bought a new position in shares of Aspen Aerogels in the third quarter worth $70,000. Occudo Quantitative Strategies LP purchased a new stake in shares of Aspen Aerogels in the third quarter worth $72,000. Finally, Clarus Group Inc. bought a new stake in Aspen Aerogels during the first quarter valued at $36,000. 97.64% of the stock is currently owned by hedge funds and other institutional investors.
Aspen Aerogels Stock Up 36.6%
Shares of NYSE:ASPN opened at $6.84 on Friday. The firm has a market capitalization of $567.23 million, a PE ratio of -5.03 and a beta of 2.99. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.54 and a current ratio of 2.89. Aspen Aerogels, Inc. has a 52-week low of $2.30 and a 52-week high of $9.78. The firm has a fifty day moving average of $5.51 and a 200 day moving average of $4.41.
Aspen Aerogels News Summary
Here are the key news stories impacting Aspen Aerogels this week:
- Positive Sentiment: Improved outlook: Aspen guided for third-quarter 2026 revenue of $65 million to $80 million, well above the roughly $56.6 million analyst consensus, and adjusted EBITDA of $7 million to $15 million. Its expected EPS loss of $0.11 to $0.07 is also better than the $0.13 consensus loss. Aspen Aerogels Second-Quarter Results
- Positive Sentiment: Thermal-barrier momentum: Second-quarter Thermal Barrier revenue reached $29.5 million, an 81% increase from the prior quarter. Aspen also raised its 2026 European Thermal Barrier revenue outlook to $20 million-$30 million, supporting expectations for continued electrification-related growth. Q2 2026 Earnings Call Transcript
- Positive Sentiment: Automotive customer win: Aspen received a PyroThin award from Jaguar Land Rover covering two next-generation vehicle architectures. The award reinforces the potential for its battery-safety materials to generate future automotive revenue. Aspen Aerogels Business Highlights
- Neutral Sentiment: Russell 1000 attention: Coverage highlighted Aspen’s Russell 1000 connection, which may increase visibility and trading interest but does not by itself change the company’s fundamentals. Russell 1000 Coverage
- Negative Sentiment: Profitability remains weak: Aspen reported a second-quarter loss of $0.22 per share, only slightly better than the $0.23 consensus estimate and worse than the $0.04 loss a year earlier. The company continues to post negative net margins and return on equity, so the stock remains dependent on successful execution of its growth plans. Aspen Aerogels Q2 Earnings Report
Wall Street Analyst Weigh In
Several research firms recently commented on ASPN. Roth Capital restated a “buy” rating and set a $5.75 target price on shares of Aspen Aerogels in a research report on Friday, May 8th. Barclays raised their price target on Aspen Aerogels from $3.00 to $4.00 and gave the company an “underweight” rating in a report on Monday, May 11th. Wall Street Zen upgraded Aspen Aerogels from a “sell” rating to a “hold” rating in a research report on Saturday, May 16th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Aspen Aerogels in a report on Wednesday, June 24th. Three analysts have rated the stock with a Buy rating, one has issued a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, Aspen Aerogels presently has an average rating of “Hold” and an average target price of $5.19.
Get Our Latest Research Report on Aspen Aerogels
About Aspen Aerogels
Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.
The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.
Featured Stories
- Five stocks we like better than Aspen Aerogels
- Sandisk Just Delivered a Blowout Quarter—Here’s Why the Stock Is Falling
- 4 Oil and Gas ETF Plays as Prices Stay Sky-High
- What Tesla Stands to Lose If It Walks Away From China
- Disney Sets Up for a Magical Year in 2027
Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.
